Showing results (31-40 of 98) with videos related to
Sort By:
Pageof 10
Journal for Immunotherapy of Cancer|October 21, 2021
High endothelial venule is a surrogate biomarker for T-cell inflamed tumor microenvironment and prognosis in gastric cancerHyung Soon Park, Yoo Min Kim, Sewha Kim, et al.Liver Cancer|August 20, 2025
Multicenter Phase 2 Trial of Second-Line Regorafenib in Patients with Unresectable Hepatocellular Carcinoma after Progression on Atezolizumab plus BevacizumabJaekyung Cheon, Baek-Yeol Ryoo, Hong Jae Chon, et al.Liver International : Official Journal of the International Association for the Study of the Liver|April 15, 2024
Organ-specific responses to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma: A multicentre, retrospective studyJaekyung Cheon, Sanghoon Jung, Jung Sun Kim, et al.Scientific Reports|January 29, 2025
Diagnostic cholangioscopy for surgical planning of extrahepatic cholangiocarcinomaMin Je Sung, Suk Pyo Shin, Chang-Il Kwon, et al.Clinical Lymphoma, Myeloma & Leukemia|July 5, 2016
Diffuse Large B-Cell Lymphoma in the Elderly: Real World Outcomes of Immunochemotherapy in Asian PopulationJa Min Byun, Jeong-Ok Lee, Beodeul Kang, et al.Journal of Hepatology|November 26, 2025
Open-label, single-arm, phase II trial to investigate the efficacy of sitravatinib plus tislelizumab combination as a second-line treatment for advanced biliary tract cancerJeesun Yoon, Choong-Kun Lee, Jin Won Kim, et al.Journal of Hepatology|October 23, 2024
Concordance of ctDNA and tissue genomic profiling in advanced biliary tract cancerSohyun Hwang, Seonjeong Woo, Beodeul Kang, et al.Journal for Immunotherapy of Cancer|June 19, 2021
STING activation normalizes the intraperitoneal vascular-immune microenvironment and suppresses peritoneal carcinomatosis of colon cancerSeung Joon Lee, Hannah Yang, Woo Ram Kim, et al.European Journal of Cancer Care|October 5, 2020
Pre-screening of patient-reported symptoms using the Edmonton Symptom Assessment System in outpatient palliative cancer careGarden Lee, Han Sang Kim, Si Won Lee, et al.Cancer Chemotherapy and Pharmacology|August 10, 2014
Phase II gemcitabine and capecitabine combination therapy in recurrent or metastatic breast cancer patients pretreated with anthracycline and taxaneJi Soo Park, Hei-Cheul Jeung, Sun Young Rha, et al.Pageof 10